Cargando…
High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial
BACKGROUND: Extubation failure is associated with increased morbidity and mortality, but cannot be safely predicted or avoided. High-flow nasal cannula (HFNC) prevents postextubation respiratory failure in low-risk patients. OBJECTIVE: To demonstrate that HFNC reduces postextubation respiratory fail...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413462/ https://www.ncbi.nlm.nih.gov/pubmed/28466461 http://dx.doi.org/10.1186/s13613-017-0270-9 |
_version_ | 1783233178724466688 |
---|---|
author | Fernandez, Rafael Subira, Carles Frutos-Vivar, Fernando Rialp, Gemma Laborda, Cesar Masclans, Joan Ramon Lesmes, Amanda Panadero, Luna Hernandez, Gonzalo |
author_facet | Fernandez, Rafael Subira, Carles Frutos-Vivar, Fernando Rialp, Gemma Laborda, Cesar Masclans, Joan Ramon Lesmes, Amanda Panadero, Luna Hernandez, Gonzalo |
author_sort | Fernandez, Rafael |
collection | PubMed |
description | BACKGROUND: Extubation failure is associated with increased morbidity and mortality, but cannot be safely predicted or avoided. High-flow nasal cannula (HFNC) prevents postextubation respiratory failure in low-risk patients. OBJECTIVE: To demonstrate that HFNC reduces postextubation respiratory failure in high-risk non-hypercapnic patients compared with conventional oxygen. METHODS: Randomized, controlled multicenter trial in patients who passed a spontaneous breathing trial. We enrolled patients meeting criteria for high-risk of failure to randomly receive HFNC or conventional oxygen for 24 h after extubation. Primary outcome was respiratory failure within 72-h postextubation. Secondary outcomes were reintubation, intensive care unit (ICU) and hospital lengths of stay, and mortality. Statistical analysis included multiple logistic regression models. RESULTS: The study was stopped due to low recruitment after 155 patients were enrolled (78 received high-flow and 77 received conventional oxygen). Groups were similar at enrollment, and all patients tolerated 24-h HFNC. Postextubation respiratory failure developed in 16 (20%) HFNC patients and in 21 (27%) conventional patients [OR 0.69 (0.31–1.54), p = 0.2]. Reintubation was needed in 9 (11%) HFNC patients and in 12 (16%) conventional patients [OR 0.71 (0.25–1.95), p = 0.5]. No difference was found in ICU or hospital length of stay, or mortality. Logistic regression models suggested HFNC [OR 0.43 (0.18–0.99), p = 0.04] and cancer [OR 2.87 (1.04–7.91), p = 0.04] may be independently associated with postextubation respiratory failure. CONCLUSION: Our study is inconclusive as to a potential benefit of HFNC over conventional oxygen to prevent occurrence of respiratory failure in non-hypercapnic patients at high risk for extubation failure. Registered at Clinicaltrials.gov NCT01820507. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-017-0270-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5413462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Paris |
record_format | MEDLINE/PubMed |
spelling | pubmed-54134622017-05-17 High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial Fernandez, Rafael Subira, Carles Frutos-Vivar, Fernando Rialp, Gemma Laborda, Cesar Masclans, Joan Ramon Lesmes, Amanda Panadero, Luna Hernandez, Gonzalo Ann Intensive Care Research BACKGROUND: Extubation failure is associated with increased morbidity and mortality, but cannot be safely predicted or avoided. High-flow nasal cannula (HFNC) prevents postextubation respiratory failure in low-risk patients. OBJECTIVE: To demonstrate that HFNC reduces postextubation respiratory failure in high-risk non-hypercapnic patients compared with conventional oxygen. METHODS: Randomized, controlled multicenter trial in patients who passed a spontaneous breathing trial. We enrolled patients meeting criteria for high-risk of failure to randomly receive HFNC or conventional oxygen for 24 h after extubation. Primary outcome was respiratory failure within 72-h postextubation. Secondary outcomes were reintubation, intensive care unit (ICU) and hospital lengths of stay, and mortality. Statistical analysis included multiple logistic regression models. RESULTS: The study was stopped due to low recruitment after 155 patients were enrolled (78 received high-flow and 77 received conventional oxygen). Groups were similar at enrollment, and all patients tolerated 24-h HFNC. Postextubation respiratory failure developed in 16 (20%) HFNC patients and in 21 (27%) conventional patients [OR 0.69 (0.31–1.54), p = 0.2]. Reintubation was needed in 9 (11%) HFNC patients and in 12 (16%) conventional patients [OR 0.71 (0.25–1.95), p = 0.5]. No difference was found in ICU or hospital length of stay, or mortality. Logistic regression models suggested HFNC [OR 0.43 (0.18–0.99), p = 0.04] and cancer [OR 2.87 (1.04–7.91), p = 0.04] may be independently associated with postextubation respiratory failure. CONCLUSION: Our study is inconclusive as to a potential benefit of HFNC over conventional oxygen to prevent occurrence of respiratory failure in non-hypercapnic patients at high risk for extubation failure. Registered at Clinicaltrials.gov NCT01820507. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-017-0270-9) contains supplementary material, which is available to authorized users. Springer Paris 2017-05-02 /pmc/articles/PMC5413462/ /pubmed/28466461 http://dx.doi.org/10.1186/s13613-017-0270-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Fernandez, Rafael Subira, Carles Frutos-Vivar, Fernando Rialp, Gemma Laborda, Cesar Masclans, Joan Ramon Lesmes, Amanda Panadero, Luna Hernandez, Gonzalo High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title | High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title_full | High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title_fullStr | High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title_full_unstemmed | High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title_short | High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
title_sort | high-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413462/ https://www.ncbi.nlm.nih.gov/pubmed/28466461 http://dx.doi.org/10.1186/s13613-017-0270-9 |
work_keys_str_mv | AT fernandezrafael highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT subiracarles highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT frutosvivarfernando highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT rialpgemma highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT labordacesar highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT masclansjoanramon highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT lesmesamanda highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT panaderoluna highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial AT hernandezgonzalo highflownasalcannulatopreventpostextubationrespiratoryfailureinhighrisknonhypercapnicpatientsarandomizedmulticentertrial |